MICROBIOLOGICAL INDICATORS OF OUTPATIENTS’ UNCOMPLICATED URINARY TRACT INFECTION
Introduction: Urinary tract infections are among the most common infections diagnosed in both outpatient and hospitalized patients, but the study of the bacterial structure and resistance of pathogens is not so widely studied at the outpatient stage.
We aimed to study microbiologic landscape and antibiotic susceptibility of strains isolated from outpatient’s urine samples.
Materials and methods: A prospective microbiological study of bacterial landscape and antibiotic susceptibility of strains isolated from 202 outpatients’ urine samples based on Microbiology Laboratory of National Scientific Medical Research Center during September 2019 to October 2020. Identification of isolates were performed by Vitek-2 automated system.
Statistical processing of the obtained data was carried out using Microsoft Excel, the average value, the error of the mean were determined, dynamic changes were determined by the method of linear regression. Differences in mean values were considered statistically significant at p<0.05
Results: During study period, 158 clinical samples were included, 75 strains were isolated; of them and the most frequently isolated microorganisms was E.coli - 76%. Antibiotic susceptibility of E.coli strains was to ampicillin – 43.8%, to III generation cephalosporins – 66.6%, to quinolones – 68.4% and to aminoglycosides – 77.1%. The highest sensitivity is observed to nitrofurantoin 94.7% and co-trimoxazole 89.4%.
Conclusion: Based on our results the most frequently pathogens of outpatients’ uncomplicated urinary tract infection was E.coli with high level of susceptibility to nitrofurantoin 94.7% and co-trimoxazole 89.4%.
Nelya M. Bissenova1, http://orcid.org/0000-0001-8722-0398
Elmira А. Tuleubyeva1, Yekaterina V. Trofimchuk1,
Aigerim S. Yergаliyevа1, http://orcid.org/0000-0003-2111-9888
Dmitryi A. Kim2, Erkebulan M. Ermaganbetov1
1 National Scientific Medical Research Center, Nur-Sultan c., Republic of Kazakhstan;
2 Municipal Policlinic №7, Nur-Sultan c., Republic of Kazakhstan.
1. Рязанцев В.Е., Власов В.В., Румянцев Ф.В., Киушкин В.О. Динамика антибиотикорезистентности у больных урологического профиля // Эффективная фармакотерапия. 2020. Т. 16. № 3. С. 8–13.
2. Методические указания по стандартам микробиологических исследований в лаборатории клинической микробиологии. Астана. 2008. С.11-12
3. Akram M., Shahid M., Khan A.U. Etiology and antibiotic resistance patterns of community-acquired urinary tract infections in J N M C Hospital Aligarh, India // Annals of Clinical Microbiology and Antimicrobials. 2007.6(4). doi.org/10.1186/1476-0711-6-4
4. Alos J.I., Serrano M.G., Gomez-Garces J.L., Perianes J. Antibiotic resistance of Escherichia coli from community-acquired urinary tract infections in relation to demographic and clinical data // Clinical Microbiology and Infection. 2005. 11 (3): P. 199-203
5. Bader M.S., Hawboldt J., Brooks A. Management of complicated urinary tract infections in the era of antimicrobial resistance. 2010 // Postgraduate Medicine. 2010. 122(6):7-15
6. Bedenic B. Urinary bactericidal activity of oral antibiotics against common urinary tract pathogens in an ex vivo model // Chemotherapy. 2006. 52(6):6293-7
7. Butler C.C., Hillier S., Roberts Z., Dunstan F., Howard A., Palmer S. Antibiotic-resistant infections in primary care are symptomatic for longer and increase workload:outcomes for patients with E.coli UTIs // Br J Gen Pract. 2006. 56:686–692
8. Driel A.A., Notermans D.W., Meima A., Mulder M., Donker G.A., Stobberingh E.E., Verbon A. Antibiotic resistance of Escherichia coli isolated from uncomplicated UTI in general practice patients over a 10-year period // Eur J Clin Microbiol Infect Dis. 2019. 38(11):2151–2158.
9. Erdem I., Ali R.K., Ardic E., Omar S.E., Mutlu R., Topkay A.E. Community-acquired lower urinary tract infections: etiology, antimicrobial resistance, and treatment results in female patients // J Glob Infect Dis. 2018.10(3):129–132. doi: 10.4103/jgid.jgid_86_17
10. Goldstein F.W. Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infections in France. Multicentre Study Group // Eur J Clin Microbiol Infect Dis. 2000, 19: 112-117
11. Keyhan H., Sedighi S., Mashayekhi B., Fathi M., Mokhtari M. Community acquired urinary tract infections’ etiological organisms and antibiotics susceptibility patterns // Nephro-Urol. 2017.9(5):e62146. doi: 10.5812/numonthly.62146.
12. Klingeberg A., Noll I., Willrich N. et al. Antibiotic-resistant E.coli in uncomplicated community-acquired urinary tract infection. A prospective cohort study from 2015/16 (the SARHA Study) compared with data from the Antimicrobial resistance surveillance system (ARS) // Dtsch Arztebl Int. 2018. 115 (29-30): 494–500.
13. Lee D.S., Lee S.J., Choe H.S. Community-acquired urinary tract infection by Escherichia coli in the era of antibiotic resistance // BioMed Research International. 2018.doi.org/10.1155/2018/7656752
14. Lee S.J., Lee D.S., Choe H.S., Shim B.S., Kim C.S., Kim M.E., Cho Y. Antimicrobial resistance in community-acquired urinary tract infections: results from the Korean Antimicrobial Resistance Monitoring System // J Infect Chemother. 2011. 17:440–446.
15. McIsaac W.J., Moineddin R., Meaney C., Mazzulli T. Antibiotic-resistant Escherichia coli in women with acute cystitis in Canada // Can J Infect Dis Med Microbiol. 2013.24:143-149.
16. Ny S., Edquista P., Dumpisc U. et al. Antimicrobial resistance of Escherichia coli isolates from outpatient urinary tract infections in women in six European countries including Russia // Journal of Global Antimicrobial Resistance. 2019. 17:25-34
17. Schito G.C., Naber K.G., Botto H., Palou J., Mazzei T., Gualco L., Marchese A. The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections // Int J Antimicrob Agents. 2009. 34(5):407-13.
18. Stapleton A.E., Wagenlehner F.M.E., Mulgirigama A., Twynholm M. Escherichia coli resistance to fluoroquinolones in community-acquired uncomplicated urinary tract infection in women: a systematic review // Antimicrob Agents Chemother. 2020.64:e00862-20. doi.org/10.1128/AAC.00862-20
19. The European Committee on Antimicrobial Susceptibility Testing. Breakpoints tables for interpretation of MICs and zone diameters. 2018. Version 8.1.
References [1-2]:
1. Ryazantsev V.E., Vlasov V.V., Rumyantsev F.V., Kiushkin V.O. Dinamika antibiotikorezistentnosti u bol'nykh urologicheskogo profilya [Dynamics of antibiotic resistance in patients with urological profile]. Effektivnaya farmakoterapiya [Effective pharmacotherapy]. 2020. T. 16. № 3. pp. 8–13. [in Russian]
2. Metodicheskie ukazaniya po standartam mikrobiologicheskikh issledovanii v laboratorii klinicheskoi mikrobiologii [Guidelines for standards of microbiological research in the Laboratory of Clinical Microbiology]. Astana. 2008. pp.11-12 [in Russian]
Number of Views: 126
Category of articles:
Original articles
Bibliography link
Bissenova N.M., Tuleubyeva E.А., Trofimchuk Ye.V., Yergаliyevа A.S., Kim D.A., Ermaganbetov E.M. Microbiological indicators of outpatients’ uncomplicated urinary tract infection // Nauka i Zdravookhranenie [Science & Healthcare]. 2022, (Vol.24) 1, pp. 47-53. doi 10.34689/SH.2022.21.1.006Related publications:
ANALYSIS OF CLINICAL AND DEMOGRAPHIC INDICATORS OF PATIENTS WITH PARKINSON'S DISEASE IN THE SOUTHERN REGION OF KAZAKHSTAN
A COMPARATIVE STUDY OF DRUG POLICY REGARDING ORPHAN DISEASES IN THE USA, THE EUROPEAN UNION, AND THE REPUBLIC OF KAZAKHSTAN
MUTATIONS IN CARDIAC ION CHANNEL GENES IN KAZAKHSTANI PATIENTS WITH LONG QT SYNDROME
GENETIC FEATURES OF CONGENITAL DYSFUNCTION OF THE ADRENAL CORTEX CAUSED BY 21-HYDROXYLASE DEFICIENCY IN PERSONS OF KAZAKH NATIONALITY
NON-MOTOR SYMPTOMS IN PARKINSON'S DISEASE USING THE EXAMPLE OF AKTOBE PATIENTS